Stay updated with breaking news from Fred Saad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AUA 2021 Phase 3 HERO Study, gonadotropin-releasing hormone (GnRH) agonists and antagonists, Relugolix vs Leuprolide, safety and efficacy of relugolix in men with advanced prostate cancer.
Published 19 January 2021 Background - To investigate the effect of frailty on short-term postoperative outcomes in patients with prostate cancer treated with radical prostatectomy (RP). Methods - Within the National Inpatient Sample database, we identified 91,618 RP patients treated between 2008 and 2015. The Johns Hopkins Adjusted Clinical Groups frailty-defining indicator was applied, and we examined the rates of frailty over time, as well as its effect on overall complications, major complications, nonhome-based discharge, length of stay (LOS), and total hospital charges (THCs). Time tr...